HitGen Inc.
HitGen Inc. (成都先导药物开发股份有限公司) is a biotechnology company headquartered in Chengdu, China. HitGen has established a drug discovery research platform for small molecules and nucleic acid drugs centred on the design, synthesis and screening of DNA encoded chemical libraries (DELs), fragment-based drug discovery (FBDD) and structure-based drug design (SBDD) technologies.
parent company
Link from a Wikipage to another Wikipage
parent
primaryTopic
HitGen Inc.
HitGen Inc. (成都先导药物开发股份有限公司) is a biotechnology company headquartered in Chengdu, China. HitGen has established a drug discovery research platform for small molecules and nucleic acid drugs centred on the design, synthesis and screening of DNA encoded chemical libraries (DELs), fragment-based drug discovery (FBDD) and structure-based drug design (SBDD) technologies.
has abstract
HitGen Inc. (成都先导药物开发股份有限公司) i ...... ug design (SBDD) technologies.
@en
founding year
industry
number of employees
number of locations
original name
成都先导药物开发股份有限公司
@en
subsidiary
Wikipage page ID
67,638,214
page length (characters) of wiki page
Wikipage revision ID
1,024,226,753
Link from a Wikipage to another Wikipage
area served
Worldwide
@en
founded
founder
Jin Li
@en
industry
Biotechnology and Pharmaceuticals
@en
key people
Jin Li , Barry Morgan
@en
logo
name
HitGen Inc.
@en
native name
成都先导药物开发股份有限公司
@en
num employees
~500
@en
num locations
subsid
Vernalis Research, HitGen Pharmaceuticals Inc.
@en
traded as
SSE: 688222.SH
@en
type
Public company
@en
website
wikiPageUsesTemplate
subject
comment
HitGen Inc. (成都先导药物开发股份有限公司) i ...... ug design (SBDD) technologies.
@en
label
HitGen Inc.
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
logo
name
HitGen Inc.
@en